These findings are consistent with our studies, which show that 1,25-D3 can activate the GLP-1R/VEGF-PI3K/AKT signaling pathway, increasing e-NOS levels, accelerating NO bioavailability, mediating vascular protection, and improving endothelial dysfunction. The gene discussed is AKT1; the disease is endothelial dysfunction.